Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05861713Phase 3Unknown
Phase 3, open-label, single-arm trial in athletic injuries and eczematous dermatitis, sponsored by Chang Gung Memorial Hospital. Primary endpoints: Change in skin symptoms at 28 days and Change in skin lesion area at 28 days. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05861713.